Drug Type Monoclonal antibody |
Synonyms LNF 1901, LNF1901 |
Target |
Action agonists |
Mechanism CD40 agonists(Tumor necrosis factor receptor superfamily member 5 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced cancer | Phase 1 | China | 01 Mar 2024 | |
Neoplasms | Phase 1 | - | 01 Feb 2024 |